Bio-Rad Laboratories reported $656.4M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Abbott USD 13.01B 423M Sep/2026
Agilent USD 1.88B 43M Jun/2026
Becton, Dickinson and Co. USD 5.3B 300M Sep/2026
Bio Techne USD 299.71M 21.49M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Danaher USD 6.55B 254M Sep/2026
General Electric Aerospace USD 14.12B 1.49B Sep/2026
Illumina USD 1.17B 10M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Merck USD 18.1B 1.5B Sep/2026
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Repligen USD 209M 5M Sep/2026
Revvity USD 729M 680K Sep/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Siemens EUR 23.68B 2.89B Sep/2026
Standard Biotools USD 20.1M 996K Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Tosoh JPY 305.5B 31.33B Sep/2026
Waters USD 1.77B 130M Sep/2026